SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-013185
Filing Date
2017-12-13
Accepted
2017-12-13 16:05:51
Documents
2
Period of Report
2017-11-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3112717bartushak_citius.html 3  
1 OWNERSHIP DOCUMENT f3112717bartushak_citius.xml 3 5025
2 POWER OF ATTORNEY f3112717ex24ibartushak_citi.htm EX-24.1 5149
  Complete submission text file 0001213900-17-013185.txt   11783
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016
Business Address
Bartushak Jaime (Reporting) CIK: 0001725077 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38174 | Film No.: 171253905